2,4-Bis(acetylamino)-2,4,6-trideoxy-D-galactose
CAS: 68567-47-5
Ref. 3D-MB167649
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar |
Información del producto
2,4-Bis(acetylamino)-2,4,6-trideoxy-D-galactose (BTDG) is a nitro derivative of L-threonine that has been derivatized with an acetyl group and a molecule of 2,4,6-trideoxygalactose. BTDG has been shown to be safe in clinical trials for vaccine development against life-threatening diseases. It is the first glycopolymer approved by the FDA for clinical use in humans. This drug has been shown to increase the antibody response and improve protection against influenza virus infection. BTDG also inhibits bacterial replication by blocking protein synthesis in some bacteria and inhibiting glycolysis in others.
Propiedades químicas
Consulta técnica sobre: 3D-MB167649 2,4-Bis(acetylamino)-2,4,6-trideoxy-D-galactose
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
